Okay Biotechnology Overview
- Year Founded
-
2018
- Status
-
Acquired/Merged
- Employees
-
52
- Latest Deal Type
-
M&A
Okay Biotechnology General Information
Description
Developer of proteins and antibodies intended for in vitro diagnostics. The company specializes in high-throughput monoclonal antibody discovery, providing clients with comprehensive solutions for antibody drug molecule development and in vitro diagnostic raw materials.
Contact Information
Website
www.okaybio.com(Operating Subsidiary)
Corporate Office
- No. 11, Puwu North Road
- Jiangbei New District
- Nanjing, Jiangsu 210000
- China
Corporate Office
- No. 11, Puwu North Road
- Jiangbei New District
- Nanjing, Jiangsu 210000
- China
Okay Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 11-Dec-2025 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 27-Jan-2021 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 05-Sep-2019 | $1.27M | $1.27M | Completed | Generating Revenue |
Okay Biotechnology Signals
Okay Biotechnology Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BGI Co-Win | Corporate Venture Capital | Minority | ||
| Nanjing High-Tech Xinchuang Investment | Government | Minority |
Okay Biotechnology FAQs
-
When was Okay Biotechnology founded?
Okay Biotechnology was founded in 2018.
-
Where is Okay Biotechnology headquartered?
Okay Biotechnology is headquartered in Nanjing, China.
-
What is the size of Okay Biotechnology?
Okay Biotechnology has 52 total employees.
-
What industry is Okay Biotechnology in?
Okay Biotechnology’s primary industry is Biotechnology.
-
Is Okay Biotechnology a private or public company?
Okay Biotechnology is a Private company.
-
What is Okay Biotechnology’s current revenue?
The current revenue for Okay Biotechnology is .
-
How much funding has Okay Biotechnology raised over time?
Okay Biotechnology has raised $1.27M.
-
Who are Okay Biotechnology’s investors?
BGI Co-Win and Nanjing High-Tech Xinchuang Investment have invested in Okay Biotechnology.
-
When was Okay Biotechnology acquired?
Okay Biotechnology was acquired on 11-Dec-2025.
-
Who acquired Okay Biotechnology?
Okay Biotechnology was acquired by Sangon Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process